Latency-Associated Nuclear Antigen 2 (LANA2) 抗体
Our Local Distributor
北京 101111
Quick Overview for Latency-Associated Nuclear Antigen 2 (LANA2) 抗体 (ABIN363228)
抗原
适用
宿主
克隆类型
应用范围
克隆位点
-
-
特异性
- Reacts with human and murin Kaposi's sarcoma-associated herpes virus (KSHV) ~66-70 kDa LANA2 protein and shows no cross-reactivity to cellular proteins
-
纯化方法
- Purified (protein G)
-
免疫原
- Recombinant LANA2 fusion protein
-
亚型
- IgG1 kappa
-
-
-
应用备注
-
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only :
- IHC : 1/10 to1/2000 - IF : 2 to 4 μg/mL - IP : 2 to 4 μg/mL - WB : 2 to 4 μg/mL -
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 2 mg/mL
-
储存条件
- 4 °C/-20 °C
-
储存方法
- Short term storage at +4°C. For extended periods store in aliquots at -20°C. Antibodies are guaranteed for 6 month from date of receipt.
-
有效期
- 6 months
-
-
- Latency-Associated Nuclear Antigen 2 (LANA2)
-
物质类
- Viral Protein
-
背景
- LANA2 (latency-associated nuclear antigen) is an inhibitor of p53-induced transcription in reporter assays and may be an apoptosis antagonist.It is a nuclear protein associated with Kaposi's sarcoma-associated herpes virus (KSHV), or human herpes virus 8.It is found in abundance in the nuclei of cultured cells from KSHV-infected hematopoietic tissues, such as PEL (primary effusion lymphoma) and CD (multicentric Castleman's disease).It does not appear to be expressed in KS (Kaposi's sarcoma) lesions.
抗原
-